BLADDER CANCER STAGE I, WITH CANCER IN SITU

BLADDER CANCER STAGE I, WITH CANCER IN SITU was reported 216 times

BLADDER CANCER STAGE I, WITH CANCER IN SITU is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
1 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
2 Platelet Aggregation Inhibitor [EPC] 3 0.0000
3 Expectorant [EPC] 1 0.0000
4 Alkylating Drug [EPC] 1 0.0000
5 Thalidomide Analog [EPC] 2 0.0000
6 beta-Adrenergic Blocker [EPC] 1 0.0000
7 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000